Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data

Trifluridine/tipiracil increases overall survival (OS) in patients with refractory, metastatic colorectal cancer (mCRC). A post hoc exploratory analysis of the RECOURSE randomized clinical trial (RCT) established two categories, a good prognosis corresponding to subjects having a low tumor burden an...

詳細記述

保存先:
書誌詳細
出版年:Sci Rep
主要な著者: Fernández Montes, Ana, Carmona-Bayonas, Alberto, Jimenez-Fonseca, Paula, Vázquez Rivera, Francisca, Martinez Lago, Nieves, Covela Rúa, Marta, Cousillas Castiñeiras, Antía, Gonzalez Villarroel, Paula, De la Cámara Gómez, Juan, Méndez, José Carlos Méndez, Carriles Fernández, Carmen, Sanchez Cánovas, Manuel, Garcia García, Teresa
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group UK 2021
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8275736/
https://ncbi.nlm.nih.gov/pubmed/34253805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-93732-5
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料